Superantigens encoded by the mouse mammary tumor virus can stimulate a large proportion of T cells through interaction with germline-encoded regions of the T cell receptor β chain like the hypervariable region 4 (HV4) loop. However, several lines of evidence suggest that somatically generated determinants in the CDR3 region might influence superantigen responses. We stimulated T cells from donors differing at the BV6S7 allele with vSAG9 to assess the nature and structure of the T cell receptor in amplified T cells and to evaluate the contribution of non-HV4 elements in vSAG recognition. This report demonstrates that vSAG9 stimulation caused the expansion of TCR BV6-expressing T cells, although to varying degrees depending on the BV6 subfamily. The BV6S7 subfamily was preferentially expanded in all donors, but in donors homozygous for the BV6S7*2 allele, a significant number of BV6S5 T cells were amplified and showed a highly biased β chain junctional region (BJ) and CDR3 usage. As CDR3 regions are involved in major histocompatibility complex (MHC)–peptide interaction, such a selection is highly suggestive of an intimate MHC–TCR interaction and would imply that the topology of the MHC-vSAG-TCR complex is similar to the one occurring during conventional antigen recognition.
Skip Nav Destination
Article navigation
19 January 1998
Brief Definitive Report|
January 19 1998
Highly Biased CDR3 Usage in Restricted Sets of β Chain Variable Regions During Viral Superantigen 9 Response
Cristina Ciurli,
Cristina Ciurli
From the *Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, Montréal (QC), Canada, H2W 1R7; ‡Département de Microbiologie–Immunologie, Faculté de Médecine, Université de Montréal, Montréal (QC), Canada, H3C 3J7; §Department of Medicine, and ‖Immunology Program, Graduate School of Medical Sciences, Cornell University Medical College, New York 10021; and ¶Department of Microbiology and Immunology, School of Medicine, McGill University, Montréal (QC), Canada, H3A 2B4
Search for other works by this author on:
David N. Posnett,
David N. Posnett
From the *Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, Montréal (QC), Canada, H2W 1R7; ‡Département de Microbiologie–Immunologie, Faculté de Médecine, Université de Montréal, Montréal (QC), Canada, H3C 3J7; §Department of Medicine, and ‖Immunology Program, Graduate School of Medical Sciences, Cornell University Medical College, New York 10021; and ¶Department of Microbiology and Immunology, School of Medicine, McGill University, Montréal (QC), Canada, H3A 2B4
Search for other works by this author on:
Rafick-Pierre Sékaly,
Rafick-Pierre Sékaly
From the *Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, Montréal (QC), Canada, H2W 1R7; ‡Département de Microbiologie–Immunologie, Faculté de Médecine, Université de Montréal, Montréal (QC), Canada, H3C 3J7; §Department of Medicine, and ‖Immunology Program, Graduate School of Medical Sciences, Cornell University Medical College, New York 10021; and ¶Department of Microbiology and Immunology, School of Medicine, McGill University, Montréal (QC), Canada, H3A 2B4
Search for other works by this author on:
François Denis
François Denis
From the *Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, Montréal (QC), Canada, H2W 1R7; ‡Département de Microbiologie–Immunologie, Faculté de Médecine, Université de Montréal, Montréal (QC), Canada, H3C 3J7; §Department of Medicine, and ‖Immunology Program, Graduate School of Medical Sciences, Cornell University Medical College, New York 10021; and ¶Department of Microbiology and Immunology, School of Medicine, McGill University, Montréal (QC), Canada, H3A 2B4
Search for other works by this author on:
Cristina Ciurli
From the *Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, Montréal (QC), Canada, H2W 1R7; ‡Département de Microbiologie–Immunologie, Faculté de Médecine, Université de Montréal, Montréal (QC), Canada, H3C 3J7; §Department of Medicine, and ‖Immunology Program, Graduate School of Medical Sciences, Cornell University Medical College, New York 10021; and ¶Department of Microbiology and Immunology, School of Medicine, McGill University, Montréal (QC), Canada, H3A 2B4
David N. Posnett
From the *Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, Montréal (QC), Canada, H2W 1R7; ‡Département de Microbiologie–Immunologie, Faculté de Médecine, Université de Montréal, Montréal (QC), Canada, H3C 3J7; §Department of Medicine, and ‖Immunology Program, Graduate School of Medical Sciences, Cornell University Medical College, New York 10021; and ¶Department of Microbiology and Immunology, School of Medicine, McGill University, Montréal (QC), Canada, H3A 2B4
Rafick-Pierre Sékaly
From the *Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, Montréal (QC), Canada, H2W 1R7; ‡Département de Microbiologie–Immunologie, Faculté de Médecine, Université de Montréal, Montréal (QC), Canada, H3C 3J7; §Department of Medicine, and ‖Immunology Program, Graduate School of Medical Sciences, Cornell University Medical College, New York 10021; and ¶Department of Microbiology and Immunology, School of Medicine, McGill University, Montréal (QC), Canada, H3A 2B4
François Denis
From the *Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, Montréal (QC), Canada, H2W 1R7; ‡Département de Microbiologie–Immunologie, Faculté de Médecine, Université de Montréal, Montréal (QC), Canada, H3C 3J7; §Department of Medicine, and ‖Immunology Program, Graduate School of Medical Sciences, Cornell University Medical College, New York 10021; and ¶Department of Microbiology and Immunology, School of Medicine, McGill University, Montréal (QC), Canada, H3A 2B4
Address correspondence to Dr. François Denis, Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montréal, 110 Av. des Pins Ouest, Montréal, Québec, Canada H2W 1R7. Phone: 514-987-5549; Fax: 514-987-5711; E-mail: [email protected]
Received:
July 17 1997
Revision Received:
October 23 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 187 (2): 253–258.
Article history
Received:
July 17 1997
Revision Received:
October 23 1997
Citation
Cristina Ciurli, David N. Posnett, Rafick-Pierre Sékaly, François Denis; Highly Biased CDR3 Usage in Restricted Sets of β Chain Variable Regions During Viral Superantigen 9 Response . J Exp Med 19 January 1998; 187 (2): 253–258. doi: https://doi.org/10.1084/jem.187.2.253
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement